TRANSCENTA-B News

TRANSCENTA-B: Next Day Disclosure Returns

Apr 23 07:04 ET

TRANSCENTA-B: Next Day Disclosure Returns

Apr 22 07:37 ET

TRANSCENTA-B: Next Day Disclosure Returns

Apr 18 07:42 ET

TRANSCENTA-B: NOTIFICATION LETTER AND REPLY FORM TO REGISTERED HOLDERS

Apr 18 04:34 ET

TRANSCENTA-B: 2023 Environmental, Social and Governance Report

Apr 18 04:33 ET

TRANSCENTA-B: NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDERS

Apr 18 04:32 ET

TRANSCENTA-B: 2023 ANNUAL REPORT

Apr 18 04:30 ET

TRANSCENTA-B: Next Day Disclosure Returns

Apr 17 06:45 ET

TRANSCENTA-B: Next Day Disclosure Returns

Apr 16 07:51 ET

TRANSCENTA-B: VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON COLLABORATION WITH AGILENT TO DEVELOP A CLAUDIN18.2 COMPANION DIAGNOSTIC TO SUPPORT OSEMITAMAB (TST001) GLOBAL PHASE III TRIAL

Apr 8 18:39 ET

TRANSCENTA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 5 04:32 ET

TRANSCENTA-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023

Mar 27 10:24 ET

TRANSCENTA-B: POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON MONDAY, MARCH 25, 2024

Mar 25 09:00 ET

TRANSCENTA-B: DATE OF BOARD MEETING

Mar 13 04:33 ET

TRANSCENTA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

Mar 5 17:01 ET

TRANSCENTA-B: NOTIFICATION LETTER AND REPLY FORM TO REGISTERED HOLDERS

Mar 5 03:36 ET

TRANSCENTA-B: NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDERS

Mar 5 03:35 ET

TRANSCENTA-B: FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON MONDAY, MARCH 25, 2024

Mar 5 03:34 ET

TRANSCENTA-B: NOTICE OF EXTRAORDINARY GENERAL MEETING

Mar 5 03:33 ET

TRANSCENTA-B: (1) GRANT OF AWARD SHARES UNDER SCHEME MANDATE LIMIT; (2) ADDITIONAL GRANT OF AWARD SHARES BEYOND SCHEME MANDATE LIMIT; (3) PROPOSED REFRESHMENT OF THE SCHEME MANDATE LIMIT AND SERVICE PROVIDER SUBLIMIT; AND (4) NOTICE OF EXTRAORDINARY GENERA

Mar 5 03:32 ET